Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab
Clinical trial NCT00891930 · COMPLETED
Trial details
- NCT number
- NCT00891930
- Sponsor
- NantBioScience, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-05
- Primary completion
- 2013-07-22
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.